Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model
Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model
复制标题
在阿尔茨海默病小鼠模型中,鼻内乳铁蛋白通过 ERK1/2-CREB 和 HIF-1 α 通路增强 α 分泌酶依赖性淀粉样前体蛋白加工
DOI:
10.1038/npp.2017.8
复制
发表时间:
2017-12-01
影响因子:
7.6
通讯作者:
Wang, Zhan-You
中科院分区:
文献类型:
--
作者:
Guo, Chuang;Yang, Zhao-Hui;Wang, Zhan-You
Growing evidence suggests that lactoferrin (Lf), an iron-binding glycoprotein, is a pleiotropic functional nutrient. In addition, Lf was recently implicated as a neuroprotective agent. These properties make Lf a valuable therapeutic candidate for the treatment of Alzheimer's disease (AD). However, the mechanisms regulating the physiological roles of Lf in the pathologic condition of AD remain unknown. In the present study, an APPswe/PS1DE9 transgenic mouse model of AD was used. We explored whether intranasal human Lf (hLf) administration could reduce beta-amyloid (A beta) deposition and ameliorate cognitive decline in this AD model. We found that hLf promoted the non-amyloidogenic metabolism of amyloid precursor protein (APP) processing through activation of alpha-secretase a-disintegrin and metalloprotease10 (ADAM10), resulting in enhanced cleavage of the alpha-COOH-terminal fragment of APP and the corresponding elevation of the NH2-terminal APP product, soluble APP-alpha (sAPP alpha), which consequently reduced A beta generation and improved spatial cognitive learning ability in AD mice. To gain insight into the molecular mechanism by which Lf modulates APP processing, we evaluated the involvement of the critical molecules for APP cleavage and the signaling pathways in N2a cells stably transfected with Swedish mutant human APP (APPsw N2a cells). The results show that the ERK1/2-CREB and HIF-1 alpha signaling pathways were activated by hLf treatment, which is responsible for the expression of induced ADAM10. Additional tests were performed before suggesting the potential use of hLf as an antioxidant and anti-inflammatory. These findings provide new insights into the sources and mechanisms by which hLf inhibits the cognitive decline that occurs in AD via activation of ADAM10 expression in an ERK1/2-CREB and HIF-1 alpha-dependent manner.